Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (5): 215-222.doi: 10.6040/j.issn.1673-3770.0.2022.411
• Review • Previous Articles
LU Gan1, DENG Yuqin1, TAO Zezhang1,2
CLC Number:
[1] Bente M. The Global Asthma Report 2022[EB/OL].(2023-03-13)[2023-03-01]. http://globalasthmareport.org/ [2] Meltzer EO. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control[J]. Immunol Allergy Clin North Am, 2016, 36(2): 235-248. doi:10.1016/j.iac.2015.12.002 [3] Colás C, Brosa M, Antón E, et al. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study[J]. Allergy, 2017, 72(6): 959-966. doi:10.1111/all.13099 [4] Avena-Woods C. Overview of atopic dermatitis[J]. Am J Manag Care, 2017, 23(8 Suppl): S115-S123 [5] Khan DA. Allergic rhinitis and asthma: epidemiology and common pathophysiology[J]. Allergy Asthma Proc, 2014, 35(5): 357-361. doi:10.2500/aap.2014.35.3794 [6] Langan SM, Irvine AD, Weidinger S. Atopic dermatitis[J]. Lancet, 2020, 396(10247): 345-360. doi:10.1016/S0140-6736(20)31286-1 [7] Fujita T, Hemmi S, Kajiwara M, et al. Complement-mediated chronic inflammation is associated with diabetic microvascular complication[J]. Diabetes Metab Res Rev, 2013, 29(3): 220-226. doi:10.1002/dmrr.2380 [8] American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022[J]. Diabetes Care. 2022, 45(Suppl 1): S17-S38. doi: 10.2337/dc22-S002 [9] Association AD. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2014, 37(Suppl 1): S81-S90. doi:10.2337/dc14-S081 [10] Dabelea D, Rewers A, Stafford JM, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study[J]. Pediatrics, 2014, 133(4): e938-e945. doi:10.1542/peds.2013-2795 [11] Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998-2013: a retrospective cohort study[J]. Diabetes Care, 2018, 41(9): 1870-1877. doi:10.2337/dc17-1583 [12] Price D, Wilson AM, Chisholm A, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice[J]. J Asthma Allergy, 2016, 9: 1-12. doi:10.2147/JAA.S97973 [13] Silverberg JI, Gelfand JM, Margolis DJ, et al. Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults[J]. Ann Allergy Asthma Immunol, 2018, 121(5): 604-612.e3. doi:10.1016/j.anai.2018.07.042 [14] Mulrennan S, Baltic S, Aggarwal S, et al. The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes[J]. Sci Rep, 2015, 5: 8931. doi:10.1038/srep08931 [15] Yu HM, Yang J, Xiao Q, et al. Regulation of high glucose-mediated mucin expression by matrix metalloproteinase-9 in human airway epithelial cells[J]. Exp Cell Res, 2015, 333(1): 127-135. doi:10.1016/j.yexcr.2015.02.007 [16] Tiwari V, Parmar HS. Diabetogenic effects of Parthinium hysterophorous induced allergic rhinitis[J]. Inflamm Allergy Drug Targets, 2012, 11(6): 492-498. doi:10.2174/187152812803590019 [17] Smew AI, Lundholm C, Sävendahl L, et al. Familial coaggregation of asthma and type 1 diabetes in children[J]. JAMA Netw Open, 2020, 3(3): e200834. doi:10.1001/jamanetworkopen.2020.0834 [18] Metsälä J, Lundqvist A, Virta LJ, et al. The association between asthma and type 1 diabetes: a paediatric case-cohort study in Finland, years 1981-2009[J]. Int J Epidemiol, 2018, 47(2): 409-416. doi:10.1093/ije/dyx245 [19] George C, Ducatman AM, Conway BN. Increased risk of respiratory diseases in adults with Type 1 and Type 2 diabetes[J]. Diabetes Res Clin Pract, 2018, 142: 46-55. doi:10.1016/j.diabres.2018.05.029 [20] Shapiro M, Arbel C, Zucker I, et al. Asthma in youth and early-onset type 2 diabetes: a nationwide study of 1.72 million Israeli adolescents[J]. J Clin Endocrinol Metab, 2021, 106(12): e5043-e5053. doi:10.1210/clinem/dgab542 [21] Baek JY, Lee SE, Han K, et al. Association between diabetes and asthma: evidence from a nationwide Korean study[J]. Ann Allergy Asthma Immunol, 2018, 121(6): 699-703. doi:10.1016/j.anai.2018.08.008 [22] Mueller NT, Koh WP, Odegaard AO, et al. Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study[J]. Diabetes Res Clin Pract, 2013, 99(2): 192-199. doi:10.1016/j.diabres.2012.11.019 [23] Rayner LH, McGovern A, Sherlock J, et al. The impact of therapy on the risk of asthma in type 2 diabetes[J]. Clin Respir J, 2019, 13(5): 299-305. doi:10.1111/crj.13011 [24] Villa-Nova H, Spinola-Castro AM, Garcia FE, et al. Prevalence of allergic diseases and/or allergic sensitisation in children and adolescents with type 1 diabetes mellitus[J]. Allergol Immunopathol(Madr), 2015, 43(2): 157-161. doi:10.1016/j.aller.2013.11.009 [25] Kowalczyk A, Szalecki M. Allergic diseases in children with type 1 diabetes[J]. Pediatr Endocrinol Diabetes Metab, 2013, 19(3): 100-105 [26] Lee TK, Jeon YJ, Jung SJ. Bi-directional association between allergic rhinitis and diabetes mellitus from the national representative data of South Korea[J]. Sci Rep, 2021, 11(1): 4344. doi:10.1038/s41598-021-83787-9 [27] Schmitt J, Schwarz K, Baurecht H, et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes[J]. J Allergy Clin Immunol, 2016, 137(1): 130-136. doi:10.1016/j.jaci.2015.06.029 [28] Drucker AM, Qureshi AA, Dummer TJB, et al. Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project[J]. Br J Dermatol, 2017, 177(4): 1043-1051. doi:10.1111/bjd.15727 [29] Andersen YMF, Egeberg A, Gislason GH, et al. Adult atopic dermatitis and the risk of type 2 diabetes[J]. J Allergy Clin Immunol, 2017, 139(3): 1057-1059. doi:10.1016/j.jaci.2016.08.049 [30] Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies[J]. J Allergy Clin Immunol, 2015, 135(3): 721-728.e6. doi:10.1016/j.jaci.2014.11.023 [31] Khateeb J, Fuchs E, Khamaisi M. Diabetes and lung disease: a neglected relationship[J]. Rev Diabet Stud, 2019, 15: 1-15. doi:10.1900/RDS.2019.15.1 [32] Padem N, Saltoun C. Classification of asthma[J]. Allergy Asthma Proc, 2019, 40(6): 385-388. doi:10.2500/aap.2019.40.4253 [33] Jones TL, Neville DM, Chauhan AJ. Diagnosis and treatment of severe asthma: a phenotype-based approach[J]. Clin Med(Lond), 2018, 18(Suppl 2): s36-s40. doi:10.7861/clinmedicine.18-2-s36 [34] D'Amato G, Ortega OPM, Annesi-Maesano I, et al. Prevention of allergic asthma with allergen avoidance measures and the role of exposome[J]. Curr Allergy Asthma Rep, 2020, 20(3): 8. doi:10.1007/s11882-020-0901-3 [35] Frisbee SJ, Brooks AP Jr, Maher A, et al. The C8 health project: design, methods, and participants[J]. Environ Health Perspect, 2009, 117(12): 1873-1882. doi:10.1289/ehp.0800379 [36] Koskela HO, Salonen PH, Romppanen J, et al. A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study[J]. BMJ Open, 2015, 5(1): e006794. doi:10.1136/bmjopen-2014-006794 [37] Zhang P, Lopez R, Attaway AH, et al. Diabetes mellitus is associated with worse outcome in patients hospitalized for asthma[J]. J Allergy Clin Immunol Pract, 2021, 9(4): 1562-1569.e1. doi:10.1016/j.jaip.2020.10.054 [38] Akirav EM, Henegariu O, Preston-Hurlburt P, et al. The receptor for advanced glycation end products(RAGE)affects T cell differentiation in OVA induced asthma[J]. PLoS One, 2014, 9(4): e95678. doi:10.1371/journal.pone.0095678 [39] Peters MC, McGrath KW, Hawkins GA, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts[J]. Lancet Respir Med, 2016, 4(7): 574-584. doi:10.1016/S2213-2600(16)30048-0 [40] Sindhu S, Koshy M, Al-Roub AA, et al. Differential association of plasma monocyte chemoattractant protein-1 with systemic inflammatory and airway remodeling biomarkers in type-2 diabetic patients with and without asthma[J]. J Diabetes Metab Disord, 2015, 15: 40. doi:10.1186/s40200-016-0264-4 [41] Bergantin LB. The interplay between asthma and other diseases: role of Ca2+/cAMP signalling[J]. Endocr Metab Immune Disord Drug Targets, 2020, 20(3): 321-327. doi:10.2174/1871530319666190828145854 [42] Zolnikova OY, Potskhverashvili ND, Kudryavtseva AV, et al. Changes in gut microbiota with bronchial asthma[J]. Ter Arkh, 2020, 92(3): 56-60. doi:10.26442/00403660.2020.03.000554 [43] Ozerskaia IV, Geppe NA, Romantseva EV, et al. Prospects for the correction of intestinal microbiota in the prevention and treatment of asthma in children[J]. Vopr Pitan, 2021, 90(4): 74-83. doi:10.33029/0042-8833-2021-90-4-74-83 [44] Gülden E, Chao C, Tai NW, et al. TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells[J]. J Autoimmun, 2018, 93: 57-65. doi:10.1016/j.jaut.2018.06.003 [45] Velloso LA, Folli F, Saad MJ. TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation[J]. Endocr Rev, 2015, 36(3): 245-271. doi:10.1210/er.2014-1100 [46] Firouzi S, Majid HA, Ismail A, et al. Effect of multi-strain probiotics(multi-strain microbial cell preparation)on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial[J]. Eur J Nutr, 2017, 56(4): 1535-1550. doi:10.1007/s00394-016-1199-8 [47] 倪璟滋, 万文锦, 程雷. 变应性鼻炎健康相关生活质量研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 110-115, 122. doi: 10.6040/j.issn.1673-3770.1.2021.165 NI Jingzi, WAN Wenjin, CHENG Lei. Research progress on health-related quality of life in allergic rhinitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 110-115, 122. doi: 10.6040/j.issn.1673-3770.1.2021.165 [48] 林一杭, 李幼瑾. 肠道微生态在儿童变应性鼻炎中的研究现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 116-122. doi: 10.6040/j.issn.1673-3770.0.2021.496 LIN Yihang, LI Youjin. Research progress on gut microbiome in children with allergic rhinitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 116-122. doi: 10.6040/j.issn.1673-3770.0.2021.496 [49] Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis[J]. Nat Rev Dis Primers, 2020, 6(1): 95. doi:10.1038/s41572-020-00227-0 [50] D'Amato G, Holgate ST, Pawankar R, et al. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization[J]. World Allergy Organ J, 2015, 8(1): 25. doi:10.1186/s40413-015-0073-0 [51] Schoemaker AA, Sprikkelman AB, Grimshaw KE, et al. Incidence and natural history of challenge-proven cow's milk allergy in European children: EuroPrevall birth cohort[J]. Allergy, 2015, 70(8): 963-972. doi:10.1111/all.12630 [52] Xepapadaki P, Fiocchi A, Grabenhenrich L, et al. Incidence and natural history of hen's egg allergy in the first 2 years of life-the EuroPrevall birth cohort study[J]. Allergy, 2016, 71(3): 350-357. doi:10.1111/all.12801 [53] Osborne NJ, Koplin JJ, Martin PE, et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants[J]. J Allergy Clin Immunol, 2011, 127(3): 668-676.e1-2. doi:10.1016/j.jaci.2011.01.039 [54] Peters RL, Koplin JJ, Gurrin LC, et al. The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up[J]. J Allergy Clin Immunol, 2017, 140(1): 145-153.e8. doi:10.1016/j.jaci.2017.02.019 [55] Gonzalez-Estrada A, Radojicic C. Penicillin allergy: a practical guide for clinicians[J]. Cleve Clin J Med, 2015, 82(5): 295-300. doi:10.3949/ccjm.82a.14111 [56] Jandus P, Harr T. Sulfonamide allergy and cross-reactivity[J]. Rev Med Suisse, 2013, 9(382): 798-802 [57] Schuler Iv CF, Montejo JM. Allergic rhinitis in children and adolescents[J]. Pediatr Clin North Am, 2019, 66(5): 981-993. doi:10.1016/j.pcl.2019.06.004 [58] Papadopoulos NG, Bernstein JA, Demoly P, et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report[J]. Allergy, 2015, 70(5): 474-494. doi:10.1111/all.12573 [59] Krischer JP, Cuthbertson D, Couluris M, et al. Association of diabetes-related autoantibodies with the incidence of asthma, eczema and allergic rhinitis in the TRIGR randomised clinical trial[J]. Diabetologia, 2020, 63(9): 1796-1807. doi:10.1007/s00125-020-05188-3 [60] Juneja L, Parmar HS. Ovalbumin induced allergic rhinitis and development of prediabetes to rats: possible role of Th2 cytokines[J]. Inflamm Allergy Drug Targets, 2013, 12(3): 199-205. doi:10.2174/1871528111312030007 [61] Meng X, Zhang G, Cao H, et al. Gut dysbacteriosis and intestinal disease: mechanism and treatment[J]. J Appl Microbiol, 2020, 129(4): 787-805. doi:10.1111/jam.14661 [62] Ni J, Friedman H, Boyd BC, et al. Early antibiotic exposure and development of asthma and allergic rhinitis in childhood[J]. BMC Pediatr, 2019, 19(1): 225. doi:10.1186/s12887-019-1594-4 [63] Miraglia Del Giudice M, Indolfi C, Capasso M, et al. Bifidobacterium mixture(B longum BB536, B infantis M-63, B breve M-16V)treatment in children with seasonal allergic rhinitis and intermittent asthma[J]. Ital J Pediatr, 2017, 43(1): 25. doi:10.1186/s13052-017-0340-5 [64] Xi Y, Jiao WE, Li F, et al. Association between 19 allergens and chronic constipation in adults: NHANES 2005-2006[J]. Int Arch Allergy Immunol, 2022: 1-9. doi:10.1159/000527159 [65] Dizon MP, Yu AM, Singh RK, et al. Systematic review of atopic dermatitis disease definition in studies using routinely collected health data[J]. Br J Dermatol, 2018, 178(6): 1280-1287. doi:10.1111/bjd.16340 [66] Paternoster L, Standl M, Waage J, et al. Multi-ancestry genome-wide association study of 21,000 cases and 95, 000 controls identifies new risk loci for atopic dermatitis[J]. Nat Genet, 2015, 47(12): 1449-1456. doi:10.1038/ng.3424 [67] Tsakok T, Woolf R, Smith CH, et al. Atopic dermatitis: the skin barrier and beyond[J]. Br J Dermatol, 2019, 180(3): 464-474. doi:10.1111/bjd.16934 [68] Halling-Overgaard AS, Kezic S, Jakasa I, et al. Skin absorption through atopic dermatitis skin: a systematic review[J]. Br J Dermatol, 2017, 177(1): 84-106. doi:10.1111/bjd.15065 [69] Baurecht H, Rühlemann MC, Rodríguez E, et al. Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration[J]. J Allergy Clin Immunol, 2018, 141(5): 1668-1676.e16. doi:10.1016/j.jaci.2018.01.019 [70] Kurita M, Yoshihara Y, Ishiuji Y, et al. Expression of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on CD4+ T cells in patients with atopic dermatitis[J]. J Dermatol, 2019, 46(1): 37-42. doi:10.1111/1346-8138.14696 [71] Spence A, Purtha W, Tam J, et al. Revealing the specificity of regulatory T cells in murine autoimmune diabetes[J]. Proc Natl Acad Sci U S A, 2018, 115(20): 5265-5270. doi:10.1073/pnas.1715590115 [72] Marro BS, Ware BC, Zak J, et al. Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling[J]. Proc Natl Acad Sci U S A, 2017, 114(14): 3708-3713. doi:10.1073/pnas.1700878114 [73] Fuhrman CA, Yeh WI, Seay HR, et al. Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226[J]. J Immunol, 2015, 195(1): 145-155. doi:10.4049/jimmunol.1402381 [74] Li Y, Xu W, Yao JY, et al. Correlation of blood FoxP3+ regulatory T cells and disease activity of atopic dermatitis[J]. J Immunol Res, 2019, 2019: 1820182. doi:10.1155/2019/1820182 [75] García EM, Galicia-Carreón J, Novak N. In vitro conversion into CD4+CD25+Foxp3+ induced regulatory T cells is reduced in atopic dermatitis patients[J]. Int Arch Allergy Immunol, 2020, 181(5): 353-356. doi:10.1159/000506285 [76] Moosbrugger-Martinz V, Gruber R, Ladstätter K, et al. Filaggrin null mutations are associated with altered circulating Tregs in atopic dermatitis[J]. J Cell Mol Med, 2019, 23(2): 1288-1299. doi:10.1111/jcmm.14031 [77] Grant CR, Liberal R, Mieli-Vergani G, et al. Regulatory T-cells in autoimmune diseases: challenges, controversies and: yet: unanswered questions[J]. Autoimmun Rev, 2015, 14(2): 105-116. doi:10.1016/j.autrev.2014.10.012 [78] Qiao YC, Pan YH, Ling W, et al. The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease[J]. Autoimmun Rev, 2017, 16(10): 1058-1070. doi:10.1016/j.autrev.2017.08.001 [79] Hull CM, Peakman M, Tree TIM. Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?[J]. Diabetologia, 2017, 60(10): 1839-1850. doi:10.1007/s00125-017-4377-1 [80] Paul M, Dayal D, Bhansali A, et al. Characterization of proinsulin-specific regulatory T cells in type 1 diabetes at different ages of onset[J]. Pediatr Diabetes, 2019, 20(3): 271-281. doi:10.1111/pedi.12813 [81] Ihantola EL, Viisanen T, Gazali AM, et al. Effector T cell resistance to suppression and STAT3 signaling during the development of human type 1 diabetes[J]. J Immunol, 2018, 201(4): 1144-1153. doi:10.4049/jimmunol.1701199 [82] Gao YR, Sun XZ, Li R, et al. The effect of regulatory T cells in Schistosoma-mediated protection against type 2 diabetes[J]. Acta Trop, 2021, 224: 106073. doi:10.1016/j.actatropica.2021.106073 [83] Leung OM, Li JT, Li XS, et al. Regulatory T cells promote apelin-mediated sprouting angiogenesis in type 2 diabetes[J]. Cell Rep, 2018, 24(6): 1610-1626. doi:10.1016/j.celrep.2018.07.019 [84] Murzina E, Kaliuzhna L, Bardova K, et al. Human skin microbiota in various phases of atopic dermatitis[J]. Acta Dermatovenerol Croat, 2019, 27(4): 245-249. [85] Melli LCFL, Carmo-Rodrigues MSD, Araújo-Filho HB, et al. Gut microbiota of children with atopic dermatitis: controlled study in the metropolitan region of São Paulo, Brazil[J]. Allergol Immunopathol(Madr), 2020, 48(2): 107-115. doi:10.1016/j.aller.2019.08.004 [86] Olaimat AN, Aolymat I, Al-Holy M, et al. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19[J]. NPJ Sci Food, 2020, 4: 17. doi:10.1038/s41538-020-00078-9 |
[1] | WANG Jian, DU Weijia, XUE Tao, CHEN Fuquan. Analysis of the epidemic characteristics of allergic rhinitis and related allergic diseases in China using Baidu index data [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 31-41. |
[2] | WANG Xiaoai, ZHANG Qianqian, CHENG Xiangyu, LI Zhipeng, ZHANG Weitian, YE Haibo. A clinical efficacy analysis of vidian neurectomy in the treatment of type 2 chronic rhinosinusitis with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 42-49. |
[3] | BI Xiaoyun, MA Benxu, WANG Xinru, LI Xuhao, YANG Jiguo. Meta-analysis of randomized controlled trials of acupoint application in treatment of children with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 75-85. |
[4] | HOU Lingxiao, ZHANG Changcui, XU Anting, FAN Xintai, WANG Na. Role of CD4+ T cells from nasal mucosa in the pathogenesis of patients with seasonal allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 96-104. |
[5] | YUAN Yue, FU Shengyao, JIANG Yan, CHEN Min. Research progress of pyroptosis in chronic airway inflammatory disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 166-171. |
[6] | WANG Weiyi, SHI Lei, ZHANG Zhiyu, ZHANG Guiling, SHI Guanggang. Effects of high fat diet on allergic rhinitis mice and intestinal flora [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 21-29. |
[7] | ZHAI Rui, LI Yuan, YU Jinglong, CHEN Xi, ZHENG Youyou, LIU Zhaolan, WANG Junhong. Meta-analysis of clinical intradermal acupuncture efficacy for treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 35-45. |
[8] | NI Jingzi, WAN Wenjin,CHENG Lei. Research progress on health-related quality of life in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 110-115. |
[9] | LIN Yihang,LI Youjin. Research progress on gut microbiome in children with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 116-122. |
[10] | LIU Zhen,SONG Xicheng. Mechanisms and research progress of pyroptosis in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 123-129. |
[11] | WANG Na,CHAI Xiangbin. Research progress on prostate-derived ETS factor in asthma and inflammatory diseases of the nasal mucosa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 136-141. |
[12] | LIU Yitong, ZHOU Suizi,QIU Qianhui. Research progress on NLRP3 inflammasome in chronic rhinosinusitis and allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 142-146. |
[13] | GONG Xiaoyang, CHENG Lei. Analysis of proportion of outpatients with allergic rhinitis during the coronavirus infectious disease 2019 pandemic [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 245-255. |
[14] | ZHANG Yaqi, LIU Huimin, CAO Linman, WANG Ziyu, LIN Xu, LI Yanping, XUE Gang, WU Jingfang. Expression and significance of the MAPK,PI3K-AKT,NF-κB pathways of allergic rhinitis in mice [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 254-259. |
[15] | LU Weili, JIANG Tao, LI Xianhua. Analysis of sIgE in polysensitized children with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 260-265. |
|